Skip to main content

Biomarkers directing melanoma immunotherapy: useful or not useful?

Intervista a Alexander M.M. Eggermont, Jeffrey A. Sosman By 4 Dicembre 2023No Comments
Congressi

At the Melanoma Bridge congress 2023 in Naples one of the Great Debate sessions is about Biomarkers directing melanoma immunotherapy: useful or not useful? We asked to explain pros and cons of both hypotheses (and some other things) to Alexander M.M. Eggermont (Professor of Clinical & Translational Immunotherapy Utrecht University, Princess Maxima Center) and Jeffrey A. Sosman (Professor of Medicine Robert H. Lurie Comprehensive Cancer Center, Northwestern Medicine), guests of the newest installment of our “Head 2 head” column.